TITLE

Markers to Detect Drinking During Pregnancy

AUTHOR(S)
Bearer, Cynthia F.
PUB. DATE
September 2001
SOURCE
Alcohol Research & Health;2001, Vol. 25 Issue 3, p210
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the development and use of biomarkers for detecting drinking during pregnancy. Examples of biomarkers; Categories of biomarkers; Biomarkers of maternal drinking during pregnancy.
ACCESSION #
7437672

 

Related Articles

  • Biobehavioral Markers of Adverse Effect in Fetal Alcohol Spectrum Disorders. Jacobson, Sandra W.; Jacobson, Joseph L.; Stanton, Mark E.; Meintjes, Ernesta M.; Molteno, Christopher D. // Neuropsychology Review;Jun2011, Vol. 21 Issue 2, p148 

    Identification of children with fetal alcohol spectrum disorders (FASD) is difficult because information regarding prenatal exposure is often lacking, a large proportion of affected children do not exhibit facial anomalies, and no distinctive behavioral phenotype has been identified. Castellanos...

  • A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. Lange, Shannon; Shield, Kevin; Koren, Gideon; Rehm, Jürgen; Popova, Svetlana // BMC Pregnancy & Childbirth;2014, Vol. 14 Issue 1, p1 

    Background Maternal self-reports, used for the detection of prenatal alcohol exposure (PAE), may lack validity, necessitating the use of an objective biomarker. The detection of fatty acid ethyl esters (products of non-oxidative ethanol metabolism) in meconium has been established as a novel...

  • Future research directions in the use of biomarkers. Hemminki, Kari; Kumar, Rajiv // Environmental Health Perspectives Supplements;May96 Supplement 3, Vol. 104, p459 

    Focuses on future research directions in the use of biomarkers. DNA adducts; Alkenes; Mutation studies in tumor suppression genes; Genetic epidemiology; Oncoproteins and growth factors; PAH adducts.

  • Would you like your telomeres tested?: A US company claims that the length of people's telomeres indicates their general state of health, but is its test reliable? McCartney, Margaret // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/11/2012, Vol. 344 Issue 7843, p31 

    The author discusses aspects of testing a person's telomeres in order to show one's general health condition, citing a telomere testing service offered by Life Length, a U.S. company. She says that the company claims to have tested samples from Great Britain, despite the tests requiring 48 hours...

  • Biomarkers of exposure to low concentrations of benzene: a field assessment. Tan, K. T.; Lee, B. L.; Ong, H. Y.; Phoon, W. H.; Ong, C. N.; Shi, C. Y.; Kok, P. W. // Occupational & Environmental Medicine;May1996, Vol. 53 Issue 5, p328 

    No abstract available.

  • Will your telomeres tell your future?: Not any time soon. von Zglinicki, Thomas // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/12/2012, Vol. 344 Issue 7856, p7 

    The article focuses on the association of short blood telomeres with various age related diseases such as cardiovascular disease. As stated, telomeres, the DNA-protein structures that protect the ends of all chromosomes, shorten with every cell division in response to intrinsic molecular factors...

  • Correction. Stolk, Jan; Veldhuisen, Barbara; Annovazzi, Laura; Zanone, Chiara; Versteeg, Elly M.; van Kuppevelt, Toine H.; Berden, Jo H. M.; Nieuwenhuizen, Willem; Iadarola, Paolo; Luisetti, Maurizio // Respiratory Research;2006, Vol. 7, p20 

    A correction to the article "Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency" that was published in the previous issue is presented.

  • Erratum to: A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis.  // Autoimmune Diseases (2090-0422);2012, p1 

    A correction to the article "A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis" that was published in a 2012 issue of the periodical is presented.

  • ASCO presentations highlight value of cancer biomarkers. Opar, Alisa // Nature Reviews Drug Discovery;Aug2008, Vol. 7 Issue 8, p666 

    A correction to the article "ASCO presentations highlight value of cancer biomarkers," that was published in the July 2008 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics